Two strategies to improve the supply of PKS extender units for ansamitocin P -3 biosynthesis by CRISPR–Cas9 | Bioresources and Bioprocessing | Full Text
Structures of maytansine and ansamitocin P3 are shown. | Download Scientific Diagram
a Biosynthetic pathway of ansamitocin P-3 (AP-3) and metabolic... | Download Scientific Diagram
Ansamitocin P-3 | ≥99%(HPLC) | microtubule depolymerizing agent | AdooQ®
Ansamitocin P-3 (Antibiotic C 15003P3) | Bacterial Inhibitor | MedChemExpress
Ansamitocin P3 Depolymerizes Microtubules and Induces Apoptosis by Binding to Tubulin at the Vinblastine Site | PLOS ONE
Ansamitocin P 3' | 66547-09-9 | MFCD01939731
Genes | Free Full-Text | Genome-Scale Metabolic Model of Actinosynnema pretiosum ATCC 31280 and Its Application for Ansamitocin P-3 Production Improvement
66584-72-3 | Ansamitocin P-3 (>85%) | Ansamitosin P-3; Antibiotic C 15003P3; Maytansinol Isobutyrate; NSC 292222 | C₃₂H₄₃ClN₂O₉ | TRC
Ansamitocin P-3 (Antibiotic C-15003P3, Maytansinol butyrate, CAS Number: 66547-09-9) | Cayman Chemical
Ansamitocin P-3 = 90 HPLC 66584-72-3
Fermentek | Ansamitocin P3 ( 66584-72-3 )
ANSAMITOCIN P-3 | 66547-09-9
Structures of maytansine and ansamitocin P3 are shown.... | Download Scientific Diagram
Maytansinol (Ansamitocin P-0) | ADC Cytotoxin | MedChemExpress
APExBIO - Ansamitocin P-3|Inhibitor of tublin spiralization,maytansine analog |CAS# 66547-09-9
Ansamitocin P 3 | C32H43ClN2O9 | ChemSpider
Ansamitocin P-3 | C32H43ClN2O9 - PubChem
Microfluidic fabrication of photo-responsive Ansamitocin P-3 loaded liposomes for the treatment of breast cancer - Nanoscale (RSC Publishing)
Mutational Biosynthesis of Ansamitocin Antibiotics: A Diversity‐Oriented Approach to Exploit Biosynthetic Flexibility - Knobloch - 2011 - ChemBioChem - Wiley Online Library
Ansamitocin - an overview | ScienceDirect Topics
Medchemexpress LLC HY-15739 100mg , Ansamitocin P-3 Antibiotic C 15003P3;Maytansinol | Fisher Scientific
Recent developments in the maytansinoid antitumor agents. | Semantic Scholar
WO2020180709A1 - Preparation of maytansinol - Google Patents
Ansamitocin P-3' | CAS#66547-09-9 | MedKoo
Ansamitocin P3-encapsulated NPs present a pH-dependent release and... | Download Scientific Diagram
Combined Muta‐ and Semisynthesis: A Powerful Synthetic Hybrid Approach to Access Target Specific Antitumor Agents Based on Ansamitocin P3 - Taft - 2012 - Chemistry – A European Journal - Wiley Online Library
